GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » ROC (Joel Greenblatt) %

Cline Scientific AB (OSTO:CLINE B) ROC (Joel Greenblatt) % : 1,882.35% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Cline Scientific AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1,882.35%.

The historical rank and industry rank for Cline Scientific AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:CLINE B' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -10908.77   Med: -1272.17   Max: -496.08
Current: -10845.35

During the past 9 years, Cline Scientific AB's highest ROC (Joel Greenblatt) % was -496.08%. The lowest was -10908.77%. And the median was -1272.17%.

OSTO:CLINE B's ROC (Joel Greenblatt) % is ranked worse than
92.71% of 1454 companies
in the Biotechnology industry
Industry Median: -333.28 vs OSTO:CLINE B: -10845.35

Cline Scientific AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -22.60% per year.


Cline Scientific AB ROC (Joel Greenblatt) % Historical Data

The historical data trend for Cline Scientific AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB ROC (Joel Greenblatt) % Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -2,619.12 -496.08 -1,137.66 -5,583.13 -10,908.77

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -564.71 -11,478.65 1,247.37 -20,931.25 1,882.35

Competitive Comparison of Cline Scientific AB's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, Cline Scientific AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's ROC (Joel Greenblatt) % falls into.



Cline Scientific AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.334 + 0 + -0.269)
=-0.065

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.241 + 0 + 1.563)
=-1.804

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Cline Scientific AB for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.48/( ( (0.029 + max(-0.065, 0)) + (0.022 + max(-1.804, 0)) )/ 2 )
=0.48/( ( 0.029 + 0.022 )/ 2 )
=0.48/0.0255
=1,882.35 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cline Scientific AB  (OSTO:CLINE B) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Cline Scientific AB ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cline Scientific AB (OSTO:CLINE B) Business Description

Traded in Other Exchanges
N/A
Address
Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB (OSTO:CLINE B) Headlines

No Headlines